ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
James T. Diehl
Delos M. Cosgrove
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diehl, J. T.
Right arrow Articles by Cosgrove, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diehl, J. T.
Right arrow Articles by Cosgrove, D. M.

Ann Thorac Surg 1982;34:674-679
© 1982 The Society of Thoracic Surgeons

Articles

Clinical Comparison of Hetastarch and Albumin in Postoperative Cardiac Patients

James T. Diehl, M.D., J. Lancelot Lester, III, M.D., Delos M. Cosgrove, M.D.*

From the Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, OH

Accepted for publication January 22, 1982.

* Address reprint requests to Dr. Cosgrove, Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44106

Hetastarch, 6% hydroxyethyl starch solution, is an artificial colloid proposed for use as a volume expander. There is concern that hetastarch, like dextran, may adversely affect coagulation. To compare the effects of hetastarch with 5% albumin in postoperative patients, 60 consecutive patients who underwent coronary artery bypass were prospectively randomized into two study groups. Both groups were comparable in all respects preoperatively. Group 1 (27 patients) received a mean of 1,241 ml of 5% albumin and Group 2 (33 patients) a mean of 1,210 ml of hetastarch as volume replacement within the first 24 postoperative hours.

Indices of postoperative hepatic, renal, and pulmonary function did not differ significantly between the groups immediately postoperatively, at 24 hours postoperatively, or at 7 days postoperatively. Hematocrits, platelet counts, prothrombin times, partial thromboplastin times, and serum fibrinogen levels were comparable between the two groups at all times. The mean volume of chest tube drainage did not differ between the groups (Group 1, 495 ± 216 ml; Group 2, 637 ± 402 ml; not significant), and no patient required reexploration for bleeding. Eighteen percent of Group 1 and 15% of Group 2 patients received banked blood during their hospitalization and required similar amounts (Group 1, 0.37 unit per patient; Group 2, 0.36 unit per patient; not significant).

The use of hetastarch as a postoperative volume expander after myocardial revascularization is safe and effective, and results in substantial financial savings.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1247 - 1259.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. C. Arora, J.-F. Legare, K. J. Buth, J. A. Sullivan, and G. M. Hirsch
Identifying Patients at Risk of Intraoperative and Postoperative Transfusion in Isolated CABG: Toward Selective Conservation Strategies
Ann. Thorac. Surg., November 1, 2004; 78(5): 1547 - 1554.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. E. Barron, M. M. Wilkes, and R. J. Navickis
A Systematic Review of the Comparative Safety of Colloids
Arch Surg, May 1, 2004; 139(5): 552 - 563.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
R. Salenger, J. S. Gammie, and T. J. Vander Salm
Postoperative Care of Cardiac Surgical Patients
Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469.
[Full Text]

Home page
 Journal of Pharmacy PracticeHome page
T. S. Aber, A. M. Hosac, M. P. Veach, and Y. W. Pierre
Fluid Therapy in the Critically Ill Patient
Journal of Pharmacy Practice, April 1, 2002; 15(2): 114 - 123.
[Abstract] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
P. R. Belcher and E. W. Muriithi
Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible?
Eur J Cardiothorac Surg, November 1, 2001; 20(5): 1078 - 1078.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. M. Wilkes, R. J. Navickis, and W. J. Sibbald
Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding
Ann. Thorac. Surg., August 1, 2001; 72(2): 527 - 533.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
D. L Zarro, D. A Palanzo, and T. G Phillips
Albumin in the pump prime: its effect on postoperative weight gain
Perfusion, March 1, 2001; 16(2): 129 - 135.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
J. E. Knutson, J. A. Deering, F. W. Hall, G. A. Nuttall, D. R. Schroeder, R. D. White, and C. J. Mullany
Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery?
Anesth. Analg., April 1, 2000; 90(4): 801 - 807.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
I. Tigchelaar, R. C. G. Huet, P. W Boonstra, and W. van Oeveren
Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients
Perfusion, September 1, 1998; 13(5): 297 - 303.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. T. Cope, D. Banks, M. C. Mauney, T. Lucktong, K. S. Shockey, I. L. Kron, and C. G. Tribble
Intraoperative Hetastarch Infusion Impairs Hemostasis After Cardiac Operations
Ann. Thorac. Surg., January 1, 1997; 63(1): 78 - 83.
[Abstract] [Full Text]

Home page
 CLIN APPL THROMB HEMOSTHome page
R. L. Bick
Evaluation of a New Hydroxyethyl Starch, Preparation (HextendTM) on Selected Coagulation Parameters
Clinical and Applied Thrombosis/Hemostasis, June 1, 1995; 1(3): 215 - 229.
[PDF]

Home page
 PerfusionHome page
L. Sandrelli, O. Alfieri II, and W. van Oeveren
The problem of priming solutions? The solution of priming problems
Perfusion, July 1, 1992; 7(3): 217 - 221.
[PDF]

Home page
 PerfusionHome page
L. B. McGrath, L. Gonzalez-Lavin, and M. J. Neary
Comparison of dextran 40 with albumin and Ringer's lactate as components of perfusion prime for cardiopulmonary bypass in patients undergoing myocardial revascularization
Perfusion, January 1, 1989; 4(1): 41 - 49.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. M. Cosgrove, F. D. Loop, B. W. Lytle, C. C. Gill, L. R. Golding, P. C. Taylor, and S. B. Forsythe
Determinants of Blood Utilization during Myocardial Revascularization
Ann. Thorac. Surg., October 1, 1985; 40(4): 380 - 384.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. L. Hicks Jr., L. A. Jensen, L. H. Norsen, J. R. Quinn, S. S. Stewart, and J. A. DeWeese
Platelet Inhibitors and Hydroxyethyl Starch: Safe and Cost-Effective Interventions in Coronary Artery Surgery
Ann. Thorac. Surg., May 1, 1985; 39(5): 422 - 425.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. T. Diehl
Hydroxyethyl Starch in CABG
Ann. Thorac. Surg., January 1, 1985; 39(1): 97 - 97.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The Society of Thoracic Surgeons.